Literature DB >> 10995467

The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

K A DeFea1, Z D Vaughn, E M O'Bryan, D Nishijima, O Déry, N W Bunnett.   

Abstract

A requirement for scaffolding complexes containing internalized G protein-coupled receptors and beta-arrestins in the activation and subcellular localization of extracellular signal-regulated kinases 1 and 2 (ERK1/2) has recently been proposed. However, the composition of these complexes and the importance of this requirement for function of ERK1/2 appear to differ between receptors. Here we report that substance P (SP) activation of neurokinin-1 receptor (NK1R) stimulates the formation of a scaffolding complex comprising internalized receptor, beta-arrestin, src, and ERK1/2 (detected by gel filtration, immunoprecipitation, and immunofluorescence). Inhibition of complex formation, by expression of dominant-negative beta-arrestin or a truncated NK1R that fails to interact with beta-arrestin, inhibits both SP-stimulated endocytosis of the NK1R and activation of ERK1/2, which is required for the proliferative and antiapoptotic effects of SP. Thus, formation of a beta-arrestin-containing complex facilitates the proliferative and antiapoptotic effects of SP, and these effects of SP could be diminished in cells expressing truncated NK1R corresponding to a naturally occurring variant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995467      PMCID: PMC27152          DOI: 10.1073/pnas.190276697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Determination of the equilibrium constants of associating protein systems. 3. Evaluation of the weight fraction of monomer from the weight-average partition coefficient (application to bovine liver glutamate dehydrogenase).

Authors:  P W Chun; S J Kim; C A Stanley; G K Ackers
Journal:  Biochemistry       Date:  1969-04       Impact factor: 3.162

2.  Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway.

Authors:  T van Biesen; B E Hawes; D K Luttrell; K M Krueger; K Touhara; E Porfiri; M Sakaue; L M Luttrell; R J Lefkowitz
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

3.  Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells.

Authors:  E Zwick; C Wallasch; H Daub; A Ullrich
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

4.  Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P.

Authors:  R Dimri; Y Sharabi; J Shoham
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells.

Authors:  D S Park; L Stefanis; C Y Yan; S E Farinelli; L A Greene
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

6.  Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells.

Authors:  M Ziche; L Morbidelli; M Pacini; P Geppetti; G Alessandri; C A Maggi
Journal:  Microvasc Res       Date:  1990-09       Impact factor: 3.514

7.  Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor.

Authors:  E F Grady; A M Garland; P D Gamp; M Lovett; D G Payan; N W Bunnett
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

8.  BAX is required for neuronal death after trophic factor deprivation and during development.

Authors:  T L Deckwerth; J L Elliott; C M Knudson; E M Johnson; W D Snider; S J Korsmeyer
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

9.  Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract.

Authors:  E F Grady; P Baluk; S Böhm; P D Gamp; H Wong; D G Payan; J Ansel; A L Portbury; J B Furness; D M McDonald; N W Bunnett
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  124 in total

Review 1.  Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase.

Authors:  Mariana M Belcheva; Carmine J Coscia
Journal:  Neurosignals       Date:  2002 Jan-Feb

2.  Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone.

Authors:  Nicoletta Bivi; Virginia Lezcano; Milena Romanello; Teresita Bellido; Lilian I Plotkin
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 3.  Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

4.  Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

5.  Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.

Authors:  Rohit Malik; Unice J K Soh; JoAnn Trejo; Adriano Marchese
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

6.  Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation.

Authors:  Geneviève Oligny-Longpré; Maithé Corbani; Joris Zhou; Mireille Hogue; Gilles Guillon; Michel Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 7.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

8.  Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism.

Authors:  John Meshki; Steven D Douglas; Jian-Ping Lai; Lynnae Schwartz; Laurie E Kilpatrick; Florin Tuluc
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

9.  beta-Arrestin 2: a Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes.

Authors:  Fahmin Basher; Hongkuan Fan; Basilia Zingarelli; Keith T Borg; Lou M Luttrell; George E Tempel; Perry V Halushka; James A Cook
Journal:  Int J Clin Exp Med       Date:  2008-01-20

10.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.

Authors:  Dane D Jensen; TinaMarie Lieu; Michelle L Halls; Nicholas A Veldhuis; Wendy L Imlach; Quynh N Mai; Daniel P Poole; Tim Quach; Luigi Aurelio; Joshua Conner; Carmen Klein Herenbrink; Nicholas Barlow; Jamie S Simpson; Martin J Scanlon; Bimbil Graham; Adam McCluskey; Phillip J Robinson; Virginie Escriou; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Gareth A Hicks; Macdonald J Christie; Christopher J H Porter; Meritxell Canals; Nigel W Bunnett
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.